Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 240

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial

Open access
Ananworanich, Jintanat, Gayet-Ageron, Angèle, Le Braz, Michelle, Prasithsirikul, Wisit, Chetchotisakd, Ploenchan, Kiertiburanakul, Sasisopin, Munsakul, Warangkana, Raksakulkarn, Phitsanu, Tansuphasawasdikul, Somboon, Sirivichayakul, Sunee, Cavassini, Matthias, Karrer, Urs, Genné, Daniel, Nüesch, Reto, Vernazza, Pietro, Bernasconi, Enos, Leduc, Dominic, Satchell, Claudette, Yerly, Sabine, Perrin, Luc, Hill, Andrew, Perneger, Thomas, Phanuphak, Praphan, Furrer, Hansjakob, Cooper, David, Ruxrungtham, Kiat, Hirschel, Bernard · 2006 · The Lancet

Abstract

BACKGROUND Stopping antiretroviral therapy in patients with HIV-1 infection can reduce costs and side-effects, but carries the risk of increased immune suppression and emergence of resistance. METHODS 430 patients with CD4-positive T-lymphocyte (CD4) counts greater than 350 cells per muL, and viral load less than 50 copies per mL were randomised to continued therapy (n=146) or scheduled treatment interruptions (n=284). Median time on randomised treatment was 21.9 months (range 16.4-25.3). Primary endpoints were proportion of patients with viral load less than 50 copies per mL at the end of the trial, and amount of drugs used. Analysis was intention-to-treat. This study is registered at ClinicalTrials.gov with the identifier NCT00113126. FINDINGS Drug savings in the scheduled treatment interruption group, compared with continuous treatment, amounted to 61.5%. 257 of 284 (90.5%) patients in the scheduled treatment interruption group reached a viral load less than 50 copies per mL, compared with 134 of 146 (91.8%) in the continued treatment group (difference 1.3%, 95% CI-4.3 to 6.9, p=0.90). No AIDS-defining events occurred. Diarrhoea and neuropathy were more frequent with continuous treatment; candidiasis was more frequent with scheduled treatment interruption. Ten patients (2.3%) had resistance mutations, with no significant differences between groups. INTERPRETATION Drug savings with scheduled treatment interruption were substantial, and no evidence of increased treatment resistance emerged. Treatment-related adverse events were more frequent with continuous treatment, but low CD4 counts and minor manifestations of HIV infection were more frequent with scheduled treatment interruption.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(06)69153-8

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 240

Metadata

Authors
Ananworanich, J., Gayet-Ageron, A., Le Braz, M., Prasithsirikul, W., Chetchotisakd, P., Kiertiburanakul, S., Munsakul, W., Raksakulkarn, P., Tansuphasawasdikul, S., Sirivichayakul, S., Cavassini, M., Karrer, U., Genné, D., Nüesch, R., Vernazza, P., Bernasconi, E., Leduc, D., Satchell, C., Yerly, S., Perrin, L., Hill, A., Perneger, T., Phanuphak, P., Furrer, H., Cooper, D., Ruxrungtham, K., & Hirschel, B.
Venue
The Lancet
Publisher
Elsevier BV
Published
2006-08
Volume
368
Issue
9534
Pages
459-465
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2126633107
Cited by
240
References
2
FWCI
21.22
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial. https://app.cochat.ai/papers/10.1016/s0140-6736(06)69153-8
The paper
Ananworanich, J., Gayet-Ageron, A., Le Braz, M., Prasithsirikul, W., Chetchotisakd, P., Kiertiburanakul, S., Munsakul, W., Raksakulkarn, P., Tansuphasawasdikul, S., Sirivichayakul, S., Cavassini, M., Karrer, U., Genné, D., Nüesch, R., Vernazza, P., Bernasconi, E., Leduc, D., Satchell, C., Yerly, S., . . . Hirschel, B. (2006). CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial. The Lancet. https://doi.org/10.1016/s0140-6736(06)69153-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.